Rhumbline Advisers Emergent Bio Solutions Inc. Transaction History
Rhumbline Advisers
- $104 Billion
- Q1 2025
A detailed history of Rhumbline Advisers transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 8,731 shares of EBS stock, worth $40,337. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,731
Previous 10,239
14.73%
Holding current value
$40,337
Previous $97,000
58.76%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding EBS
# of Institutions
174Shares Held
36.5MCall Options Held
336KPut Options Held
203K-
Black Rock Inc. New York, NY3.84MShares$17.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.2MShares$14.8 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.14MShares$9.88 Million0.01% of portfolio
-
State Street Corp Boston, MA1.96MShares$9.07 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.54MShares$7.11 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $230M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...